Skip to main content
. 2023 Jan 24;29(9):1719–1729. doi: 10.1158/1078-0432.CCR-22-2177

Figure 1.

Figure 1. Overview of study design. A, Study schema. B, Sample collection timepoints for PredicineCNB and PredicineWES+ profiling. C, Next-generation sequencing process. Abbreviations: BL, baseline; PD, progressive disease; QC, quality control; C1D15, cycle 1, day 15; C2D1 = cycle 2, day 1; gDNA, genomic DNA; cfDNA, cell-free DNA.

Overview of study design. A, Study schema. B, Sample collection timepoints for PredicineCNB and PredicineWES+ profiling. C, Next-generation sequencing process. BL, baseline; C1D15, cycle 1 day 15; C2D1, cycle 2 day 1; cfDNA, cell-free DNA; gDNA, genomic DNA; PD, progressive disease; QC, quality control.